Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
EEG Microstates Reveal Differences in Adults With ADHD
01/17/2022
A specific cerebral activity state, detectable using electroencephalography (EEG) and associated with sleep and attention, lasted longer in adults with ADHD than in adults without ADHD, according to a study.
A specific cerebral activity state, detectable using electroencephalography (EEG) and associated with sleep and attention, lasted longer in adults with ADHD than in adults without ADHD, according to a study.
A specific cerebral activity...
01/17/2022
Psych Congress Network

Advertisement

News
Self-Administered Test Detects Dementia Progression Sooner Than MMSE
01/14/2022
A self-administered cognitive test that takes about 10 to 15 minutes to complete identified patients with mild cognitive impairment who eventually progressed to dementia half a year earlier than the Mini-Mental State Examination (MMSE),...
A self-administered cognitive test that takes about 10 to 15 minutes to complete identified patients with mild cognitive impairment who eventually progressed to dementia half a year earlier than the Mini-Mental State Examination (MMSE),...
A self-administered cognitive...
01/14/2022
Psych Congress Network
News
Buprenorphine Treatment Access Equitable in Areas Where Medicaid is Prevalent
01/14/2022
In areas where Medicaid coverage is more common, providers of buprenorphine treatment are much less likely to discriminate between prospective patients with Medicaid and those with private insurance, according to a study published in Health...
In areas where Medicaid coverage is more common, providers of buprenorphine treatment are much less likely to discriminate between prospective patients with Medicaid and those with private insurance, according to a study published in Health...
In areas where Medicaid coverage...
01/14/2022
Psych Congress Network
News
First Exposure to Deutetrabenazine Well-Tolerated Across Patient Populations
01/11/2022
Analysis of safety data for deutetrabenazine suggests the drug is generally safe and well-tolerated in both tardive dyskinesia and chorea associated with Huntington's disease patient populations.
Analysis of safety data for deutetrabenazine suggests the drug is generally safe and well-tolerated in both tardive dyskinesia and chorea associated with Huntington's disease patient populations.
Analysis of safety data for...
01/11/2022
Psych Congress Network

Advertisement

News
Mood Disorders Associated With Significant ADHD Risk
01/11/2022
ADHD is 3 times more common in people with mood disorders compared to people without mood disorders, according to findings from a systematic review and meta-analysis.
ADHD is 3 times more common in people with mood disorders compared to people without mood disorders, according to findings from a systematic review and meta-analysis.
ADHD is 3 times more common in...
01/11/2022
Psych Congress Network
News
Amendment Allows Canadian Physicians to Request Access to Psychedelic Treatments
01/11/2022
Health Canada announced it has amended its Special Access Program to allow qualified physicians to request access to psychedelic treatments for serious, treatment-resistant or life-threatening health conditions when other therapies have...
Health Canada announced it has amended its Special Access Program to allow qualified physicians to request access to psychedelic treatments for serious, treatment-resistant or life-threatening health conditions when other therapies have...
Health Canada announced it has...
01/11/2022
Psych Congress Network
News
Recent Survey Provides Insights on Bipolar Disorder
01/07/2022
A new survey highlights insights from US-based adults living with bipolar I disorder (BD-I) about treatment experiences and living with a mental health condition.
A new survey highlights insights from US-based adults living with bipolar I disorder (BD-I) about treatment experiences and living with a mental health condition.
A new survey highlights insights...
01/07/2022
Psych Congress Network

Advertisement

News
Risk of COVID-19 Death Nearly 4 Times Higher in People with Schizophrenia
01/06/2022
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had...
01/06/2022
Psych Congress Network
News
Specific Brain Pathways Predict ADHD Impulsivity
01/04/2022
Impulsivity differences in young people with ADHD can be predicted by the limbic and executive meso- and nigrostriatal tracts in the brain, suggest study findings published online ahead of print.
Impulsivity differences in young people with ADHD can be predicted by the limbic and executive meso- and nigrostriatal tracts in the brain, suggest study findings published online ahead of print.
Impulsivity differences in young...
01/04/2022
Psych Congress Network
News
Consensus Paper Challenges ADHD Misconceptions with 200-Plus Evidence-Based Facts
12/24/2021
ADHD is a valid mental health diagnosis with the potential to improve the lives of people lives with ADHD and its complications worldwide.
ADHD is a valid mental health diagnosis with the potential to improve the lives of people lives with ADHD and its complications worldwide.
ADHD is a valid mental health...
12/24/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use